Ultragenyx Rebounds After Volatile Session

16 days ago

Alexandra Seinova

"Yeah, here's one that is trading a little bit like a meme stock as they often do in the sector. This is ultragenics pharmaceutical that is ticker rare. share sore today looks like 15% here. That is the biggest move since January of 2020. Uh Jeffrey's analysts say the stock could rebound in 2026. So what happened here was it actually plunged more than 40% yesterday and this is a somewhat of a recovery here. Uh Jeffrey's also giving it a little bit of a boost with its positive outlook. Analysts highlight that the company is maintaining 2027 profitability guidance and will provide guidance on exposure reductions in early 2026. These stocks often see really big swings in either direction here to the upside today."

Ultragenyx, trading under ticker RARE, experienced a 15% surge after a sharp 40% plunge the previous day. Analysts are optimistic about a rebound in 2026, supported by maintained profitability guidance and upcoming exposure reduction plans, though the stock remains volatile like many meme stocks in the biotech sector.

Related Stocks